GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cocrystal Pharma Inc (STU:8CC) » Definitions » Float Percentage Of Total Shares Outstanding

Cocrystal Pharma (STU:8CC) Float Percentage Of Total Shares Outstanding : 76.15% (As of May. 24, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cocrystal Pharma Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cocrystal Pharma's float shares is 7.74 Mil. Cocrystal Pharma's total shares outstanding is 10.17 Mil. Cocrystal Pharma's float percentage of total shares outstanding is 76.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cocrystal Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cocrystal Pharma's Institutional Ownership is 4.89%.

Cocrystal Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cocrystal Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=7.74/10.17
=76.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cocrystal Pharma (STU:8CC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cocrystal Pharma Inc (STU:8CC) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
APRE AKTX CLCS SNSE IGC NRBO TCRT NTBL CNTX NTRB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
COCP:USA
Address
19805 North Creek Parkway, Bothell, WA, USA, 98011
Website
https://www.cocrystalpharma.com
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Cocrystal Pharma (STU:8CC) Headlines

No Headlines